Patents by Inventor Allan Uldam

Allan Uldam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MUSCARINIC AGONISTS
    Publication number: 20070155795
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of cholinergic, especially muscarinic m1, m4, or both m1 and m4, receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Application
    Filed: February 16, 2007
    Publication date: July 5, 2007
    Applicant: ACADIA Pharmaceuticals Inc.
    Inventors: Carl-Magnus Andersson, Bo Lennart Friberg, Niels Skjaerbaek, Tracy Spalding, Allan Uldam
  • Azacyclic compounds
    Publication number: 20060194778
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Application
    Filed: May 3, 2006
    Publication date: August 31, 2006
    Inventors: Carl-Magnus Andersson, Glenn Croston, E. Hansen, Allan Uldam
  • Azacyclic compounds
    Publication number: 20060194834
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Application
    Filed: May 3, 2006
    Publication date: August 31, 2006
    Inventors: Carl-Magnus Andersson, Glenn Croston, E. Hansen, Allan Uldam
  • Muscarinic agonists
    Publication number: 20050113357
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of cholinergic, especially muscarinic m1, m4, or both m1 and m4, receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Application
    Filed: July 17, 2003
    Publication date: May 26, 2005
    Inventors: Carl-Magnus Anderson, Bo Friberg, Niels Skjaerbaek, Tracy Spalding, Allan Uldam
  • Azacyclic compounds
    Publication number: 20050014757
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
    Type: Application
    Filed: March 16, 2004
    Publication date: January 20, 2005
    Inventors: Carl-Magnus Andersson, Glenn Croston, E.L. Hansen, Allan Uldam